← All organizations
Highest phase reached
Phase 3
First clinical trial
Dec 30, 2018Last known activity
Dec 31, 2025
Timeline
2010s
- Jan 25, 2018
Reistone Biopharma Company Limited— Founded
Drugs by trial phase (4 distinct, 13 trials)
Phase 3 (1 own, 0 via acquisition)
Phase 1 (1 own, 0 via acquisition)
Indications
Recent trials (13)
- NCT07289464Lead sponsorPhase 1Dec 31, 2025
- NCT07158151Lead sponsorPhase 2Sep 25, 2025
- NCT05470413Lead sponsorPhase 3Apr 18, 2022
- NCT05181137Lead sponsorPhase 3Nov 5, 2021
- NCT05136456Lead sponsorPhase 2Nov 5, 2021
- NCT04875169Lead sponsorPhase 3Apr 30, 2021
- NCT04670770Lead sponsorPhase 2Dec 31, 2020
- NCT04717310Lead sponsorPhase 2/Phase 3Dec 30, 2020
- NCT04346316Lead sponsorPhase 2Apr 30, 2020
- NCT04774809Lead sponsorPhase 2/Phase 3Jan 29, 2020
- NCT04162899Lead sponsorPhase 2Nov 15, 2019
- NCT03675477Lead sponsorPhase 2Dec 30, 2018
- NCT03677648Lead sponsorPhase 2Dec 30, 2018
Details
- Founded
- Hong Kong, HK Jan 25, 2018
- Last known activity
- Dec 31, 2025